Theme: AI×Drug Discovery: Infinite Possibilities!? Exploring the Future of Drug Development Unveiled by Nobel Prize Research  Date: November 18(Tue) – 20(Thu), 2025  Venue: Awagin Hall  Hosted By: The Pharmaceutical Society of Japan Division of Medicinal Chemistry  Sponsorship: The Pharmaceutical Society Japan Division of Organic Chemistry, Division of Pharma-Biology, Division of Structure-Activity Studies, Division of Natural Medicines, Division of Physical Sciences, Division of Pharmacology and Drug Therapeutics, Chem-Station

Sato Memorial International Award Lecture

Expanding the Repertoire of Druggable Targets

Angela N. Koehler (Massachusetts Institute of Technology)

Invited Lectures (Alphabetical order in Japanese)

Aiming for Innovation in Pharmaceutical Production through Mechanochemical Organic Synthesis

Hajime Ito (Hokkaido University)

Next-generation Antibody Molecular Design using Machine Learning

Atsushi Ohta (Chugai Pharmaceutical Co., Ltd.)

Nonaqueous Bioconjugation for Functionalization of Therapeutic Proteins

Jun Ohata (North Carolina State University)

Total Syntheses of Alkaloids featuring Late-Stage Oxidative Transformations

Hidetoshi Tokuyama (Tohoku University)

Advancement from Peptide Chemistry to Drug Discovery and Chemical Biology

Yoshio Hayashi (Tokyo University of Pharmacy and Life Sciences)

Application of Artificial Intelligence to Drug Discovery Research at Astellas Pharma

Kenichi Mori (Astellas Pharma Inc.)

Innovations in Diabetes and Obesity Treatment through Incretin-Based Peptide Drug Discovery

Daisuke Yabe (Kyoto University)

Innovative Encounters:AI Pharma Connect (Alphabetical order in Japanese)

Masahito Ohue (Institute of Science Tokyo)
Ryushi Seo (Xeureka Inc.)
Yoshihiro Yamanishi (Nagoya University)

The Medicinal Chemistry Symposium invites a wide range of participants from industry, academia, and government, and aims to revitalize and improve the level of pharmaceutical research and development in Japan. There is a large variety of presentations and lectures on "the latest science, technology and information related to drug discovery."
The symposium consists of general poster presentations (including short presentations), invited lectures, and special lectures.
Through these presentations, we will share information and exchange opinions about current issues and prospects in drug discovery, thereby contributing to the revitalization of future drug discovery research and the creation of new drugs originating from Japan. We also aim to foster a drug discovery mindset and motivation among young medicinal scientists and students studying medicinal chemistry.

What's new

May. 22, 2025
Website has opened.
  • poster

Secretariat

Executive Committee Chairperson: Akira Otaka (Tokushima University)
1-78-1, Sho-machi, Tokushima-shi, Tokushima, 770-8505, Japan

Management cooperation

KOHMURA Inc.
3 Miwa Purintopia, Gifu-shi, Gifu, 501-2517, Japan
E-mail: mcs2025[at]kohmura.co.jp *Please replace [at] in the email address with @.